Cargando…
Disease-modifying drugs for Alzheimer disease: implications for people in Canada
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
CMA Impact Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615338/ https://www.ncbi.nlm.nih.gov/pubmed/37903526 http://dx.doi.org/10.1503/cmaj.230595 |
| _version_ | 1785129201756536832 |
|---|---|
| author | Watt, Jennifer A. Isaranuwatchai, Wanrudee Grossman, Linda Straus, Sharon E. |
| author_facet | Watt, Jennifer A. Isaranuwatchai, Wanrudee Grossman, Linda Straus, Sharon E. |
| author_sort | Watt, Jennifer A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10615338 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | CMA Impact Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106153382023-10-31 Disease-modifying drugs for Alzheimer disease: implications for people in Canada Watt, Jennifer A. Isaranuwatchai, Wanrudee Grossman, Linda Straus, Sharon E. CMAJ Commentary CMA Impact Inc. 2023-10-30 2023-10-23 /pmc/articles/PMC10615338/ /pubmed/37903526 http://dx.doi.org/10.1503/cmaj.230595 Text en © 2023 CMA Impact Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| spellingShingle | Commentary Watt, Jennifer A. Isaranuwatchai, Wanrudee Grossman, Linda Straus, Sharon E. Disease-modifying drugs for Alzheimer disease: implications for people in Canada |
| title | Disease-modifying drugs for Alzheimer disease: implications for people in Canada |
| title_full | Disease-modifying drugs for Alzheimer disease: implications for people in Canada |
| title_fullStr | Disease-modifying drugs for Alzheimer disease: implications for people in Canada |
| title_full_unstemmed | Disease-modifying drugs for Alzheimer disease: implications for people in Canada |
| title_short | Disease-modifying drugs for Alzheimer disease: implications for people in Canada |
| title_sort | disease-modifying drugs for alzheimer disease: implications for people in canada |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10615338/ https://www.ncbi.nlm.nih.gov/pubmed/37903526 http://dx.doi.org/10.1503/cmaj.230595 |
| work_keys_str_mv | AT wattjennifera diseasemodifyingdrugsforalzheimerdiseaseimplicationsforpeopleincanada AT isaranuwatchaiwanrudee diseasemodifyingdrugsforalzheimerdiseaseimplicationsforpeopleincanada AT grossmanlinda diseasemodifyingdrugsforalzheimerdiseaseimplicationsforpeopleincanada AT straussharone diseasemodifyingdrugsforalzheimerdiseaseimplicationsforpeopleincanada |